 |
|
|
We have discovered a little known |
|
|
Chinese firm with total assets of $36m. |
|
|
Released on Tuesday, November 8, 2011, 11:30 AM ET
Pittsburgh, PA (SpeculatingStocks) - When you think of mergers and acquisitions formulating the massive multinational conglomerate private equity groups such as Kohlberg Kravis Roberts or even Warren Buffett’s prized Berkshire Hathaway come to mind, but you are rarely struck with any inclination to a corporation that is but a puny fraction of that size.
Isn’t a private equity firm supposed to help small firms get a leg up on the competition, become what they can truly be? Then how would a private equity firm with a total market-capitalization of only around $19 million be any good? Well it just so happens that this would-be conglomerate corporation is—and they are in China—what better place for growth and expansion!
Prime Acquisition Corporation (NASDAQ:PACQ) is interesting for several reasons, first of which it has a market capitalization that is trading well below what the company has in assets—which total to $36 million and compared to a total debt of only $1.5 million, this company is otherwise firm on its feet.
PACQ is trading at $9.41 per share (11:30 AM EDT, November 8th, 2011), but watch out it likes to trade sparingly, as volume averages 196 shares a month, but the last trade was 52,500 shares. This lack of volume could be attributed to the fact that the stock only listed beginning in March of 2011. As always, be sure to note when volume will be down in trading, as you may not be able to get your investment out—even if the stock is plummeting.
PACQ seems to hold a support at $9.40 per share, and has rarely crossed below this mark since its IPO at $10.00 a share. And one of the great things about this firm is that it is based internationally in China. To be sure the company is just getting underway, and an investment now could be the investment of a lifetime if PACQ is able to sustain itself into the future.
Find more stocks on the SpeculatingStocks homepage.
Comments: